Safety, Tolerability & Immunogenicity of the Recombinant Plague Vaccine rF1V

This study has been completed.

Study NCT00097396 Information provided by DynPort Vaccine Company LLC, A CSC Company

First Received: November 23, 2004 Last Updated: September 25, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	September 2006
Estimated Primary Completion Date:	No date given